Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chu

Showing results (431-440 of 495) with videos related to

Pageof 50
Sort By:
Blood Neoplasia|May 25, 2026
Real-world outcomes of patients with multiple myeloma who reach third-line therapy: a Canadian reportMartha L Louzada, Donna Reece, Christopher P Venner, et al.
Transplantation and Cellular Therapy|July 6, 2024
Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group DatabaseChristopher P Venner, Peter Duggan, Kevin Song, et al.
The Journal of Experimental Medicine|March 12, 2014
Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemiaMarcus Järås, Peter G Miller, Lisa P Chu, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 18, 2023
Yttrium-90 Activity Quantification in PET/CT-Guided Biopsy Specimens from Colorectal Hepatic Metastases Immediately after Transarterial Radioembolization Using Micro-CT and AutoradiographyNicola Naydenov, Alexei Teplov, Mahdi Zadeh Zirakchian, et al.
Nature Medicine|October 2, 2023
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trialNizar J Bahlis, Caitlin L Costello, Noopur S Raje, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2025
Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group DatabaseRayan Kaedbey, Christopher P Venner, Donna Reece, et al.
Blood Cancer Journal|September 5, 2023
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group databaseJulie Côté, Richard LeBlanc, Hira Mian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2025
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell LymphomaMichael Wang, David Salek, David Belada, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 28, 2025
Real-World Outcomes in Myeloma Patients With t (11;14): A Matched Comparison Using the Canadian Myeloma Research Group National Clinical DatabaseJulia Varghese, Christopher P Venner, Martha Louzada, et al.
Cancer Medicine|November 5, 2024
Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies: A Canadian Myeloma Research Group Database StudyMégane Tanguay, Jean Roy, Jiandong Su, et al.
Pageof 50

Showing results (431-440 of 495) with videos related to

Sort By:
Pageof 50
Blood Neoplasia|May 25, 2026
Real-world outcomes of patients with multiple myeloma who reach third-line therapy: a Canadian reportMartha L Louzada, Donna Reece, Christopher P Venner, et al.
Transplantation and Cellular Therapy|July 6, 2024
Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group DatabaseChristopher P Venner, Peter Duggan, Kevin Song, et al.
The Journal of Experimental Medicine|March 12, 2014
Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemiaMarcus Järås, Peter G Miller, Lisa P Chu, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 18, 2023
Yttrium-90 Activity Quantification in PET/CT-Guided Biopsy Specimens from Colorectal Hepatic Metastases Immediately after Transarterial Radioembolization Using Micro-CT and AutoradiographyNicola Naydenov, Alexei Teplov, Mahdi Zadeh Zirakchian, et al.
Nature Medicine|October 2, 2023
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trialNizar J Bahlis, Caitlin L Costello, Noopur S Raje, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2025
Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group DatabaseRayan Kaedbey, Christopher P Venner, Donna Reece, et al.
Blood Cancer Journal|September 5, 2023
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group databaseJulie Côté, Richard LeBlanc, Hira Mian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2025
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell LymphomaMichael Wang, David Salek, David Belada, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 28, 2025
Real-World Outcomes in Myeloma Patients With t (11;14): A Matched Comparison Using the Canadian Myeloma Research Group National Clinical DatabaseJulia Varghese, Christopher P Venner, Martha Louzada, et al.
Cancer Medicine|November 5, 2024
Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies: A Canadian Myeloma Research Group Database StudyMégane Tanguay, Jean Roy, Jiandong Su, et al.
Pageof 50